ArticleBMC cancer2026
Leveraging data-driven risk-adapted surveillance strategies after disease progression in locally advanced rectal cancer.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPost-progression survival (PPS) is a critical endpoint in oncology, yet predictors of PPS and data-driven strategies for post-progression management in locally advanced rectal cancer (LARC) remain undefined. This study aimed to identify prognostic factors for PPS, develop a predictive tool, and formulate risk-adapted surveillance strategies based on conditional survival to optimize long-term patient management.
methodsThe relationship between PPS and overall survival (OS) using spearman analysis. Independent predictors of PPS were identified through a combination of LASSO regression, machine learning approaches, and Cox regression, and a PPS prediction model was constructed. Model interpretability was elucidated using SHAP. Conditional PPS survival rates and annual recurrence risks were evaluated using Kaplan-Meier curve. Restricted cubic spline (RCS) analyses were employed to explore the association between a risk score and PPS.
resultsAmong the cohort, 161 patients experienced disease progression. PPS was positively correlated with OS. Vascular tumor thrombus, perineural invasion, extramural venous invasion, body mass index, tumor size, and lymphocyte-to-monocyte ratio were identified as independent prognostic factors. The model achieved AUCs of 0.767, 0.801, and 0.802 at 1, 3, and 5 years, respectively, outperforming individual variables and TNM staging. The C-index of the model is 0.745. RCS analysis indicated a nonlinear relationship between higher risk score and worse PPS. After adjusting for other confounders, multi-model analysis demonstrated further supporting the positive association between risk score and adverse outcomes. Conditional survival analyses revealed that, across risk groups, longer PPS corresponded to higher survival probabilities and lower recurrence risks. Based on these findings, follow-up strategies should implement intensive surveillance for high-risk patients while adopting relatively streamlined monitoring for low-risk patients.
conclusionThis study provides the first integrated, data-driven framework for predicting PPS and personalizing surveillance in LARC. The validated nomogram and conditional survival-based strategies enable risk-adapted follow-up, supporting a shift from empirical to evidence-based management after disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.